iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
0 hedge funds and large institutions have $0 invested in iKang Healthcare Group, Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 53 closing their positions.
100% less funds holding
Funds holding: 54 → 0 (-54)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $379M → $0 (-$379M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 53
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$94.3M |
| 2 |
Goldman Sachs
New York
|
-$89.1M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$59.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$30.4M |
| 5 |
BlackRock
New York
|
-$22.6M |
KANG Hedge Fund Activity: Q1 2019 in Review
0 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q1 2019, worth a combined $0 — down 100% from $379M a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of KANG and 0 opened new positions — a net loss of 53 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fosun International, exiting entirely with an estimated $94.3M sold.
- 0 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q1 2019, down from 54 in Q4 2018.
- Funds reported $0 of iKang Healthcare Group, Inc. stock for Q1 2019, down 100% quarter-over-quarter.
- 0 funds opened new iKang Healthcare Group, Inc. positions in Q1 2019 and 53 closed out, a net change of -53 holders.
- The largest iKang Healthcare Group, Inc. seller in Q1 2019 was Fosun International, an estimated $94.3M sold.
Based on aggregated 13F filings for Q1 2019.